TIME honors Butterfly’s role in advancing accessible diagnostic imaging

Butterfly Network, Inc. (“Butterfly”, “the Company”) (NYSE: BFLY), a digital health company transforming care with handheld, whole-body ultrasound, today announced its inclusion in the first edition of the World’s Top HealthTech Companies 2025, presented by TIME and Statista Inc., the world-leading statistics portal and industry ranking provider.

The World’s Top HealthTech Companies 2025 ranking recognizes leading innovators advancing healthcare globally through technology. Companies were evaluated using three primary data sources: Financial Performance Metrics, Reputation Analysis and Online Engagement. Out of thousands of HealthTech companies reviewed, 400 were recognized for their leading performance across these critical areas.

This honor reinforces Butterfly’s innovation as it works towards making ultrasound more affordable, sustainable and scalable by integrating hardware, AI workflow software and cloud connectivity. Powered by its Ultrasound-on-Chip™ technology, Butterfly has reimagined traditional systems into a single, whole-body handheld probe. The latest award-winning iQ3 device delivers enhanced AI-powered features and sharp image capture, empowering healthcare workers to bring advanced diagnostic imaging directly to the point of care. From resource-limited settings to advanced hospital systems, Butterfly helps close critical gaps in healthcare delivery, supporting earlier detection, faster diagnosis and improved patient outcomes.

"We are proud to be included on TIME’s List of the World’s Top HealthTech Companies,” said Joseph DeVivo, President, CEO, and Chairman of Butterfly Network. “This recognition reflects both our continuous hardware and software innovation as well as our commitment to democratizing ultrasound, enabling healthcare workers to improve outcomes and transform the lives of patients worldwide.”

To view the full list of 2025 honorees, please visit: https://time.com/7318020/worlds-top-healthtech-companies-2025/.

About Butterfly Network

Butterfly Network, Inc. (NYSE: BFLY) is a healthcare company driving a digital revolution in medical imaging with its proprietary Ultrasound-on-Chip™ semiconductor technology and ultrasound software solutions. In 2018, Butterfly launched the world’s first handheld, single-probe, whole-body ultrasound system, Butterfly iQ. The iQ+ followed in 2020, and the iQ3 in 2024, each with improved processing power and performance by leveraging Moore’s Law. The iQ3 earned Best Medical Technology at the 2024 Prix Galien USA Awards, a prestigious honor and one of the highest accolades in healthcare. Butterfly’s innovations have also been recognized by Fierce 50, TIME’s Best Inventions and Fast Company’s World Changing Ideas, among other achievements.

Butterfly combines advanced hardware, intelligent software, AI, services, and education to drive adoption of affordable, accessible imaging. Clinical publications demonstrate that its handheld ultrasound probes paired with Compass™ enterprise workflow software, can help hospital systems improve care workflows, reduce costs, and enhance provider economics. With a cloud-based solution that enables care anywhere through next-generation mobility, Butterfly aims to democratize healthcare by addressing critical global healthcare challenges. Butterfly devices are commercially available to trained healthcare practitioners in areas including, but not limited to, parts of Africa, Asia, Australia, Europe, the Middle East, North America and South America; to learn more about available countries, visit: https://www.butterflynetwork.com/choose-your-country.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250918413883/en/